During the past decade, Urologic Associates of Allentown conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Urologic Associates of Allentown" are "Prostate Cancer" (3 trials), "Fractures" (1 trials), "Osteoporosis" (1 trials), "Preneoplastic Conditions" (1 trials) and "Prostatic Intraepithelial Neoplasia" (1 trials). Many other conditions were trialed in "Urologic Associates of Allentown" in a lesser frequency.

Most popular intervention types in "Urologic Associates of Allentown" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Atrasentan" (2 trials), "Placebo" (1 trials), "Toremifene 20 mg" (1 trials), "Toremifene Citrate" (1 trials) and "zoledronic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Urologic Associates of Allentown" are 5 trials for "Male" genders.

Currently, there are NaN active trials in "Urologic Associates of Allentown". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Urologic Associates of Allentown, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Urologic Associates of Allentown, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".